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Abstract
Background: The number of colonoscopies tremendously increased in recent years and will further rise in the near
future. Because of patients’ growing expectation on comfort during medical procedures, it is not surprising that the
demand for sedation also expands. Propofol in combination with alfentanil is known to provide excellent
analgosedation, however, its use is associated with respiratory and cardiovascular depression. Acupuncture could be
a technique to reduce drug requirement while providing the same level of sedation and analgesia.
Methods/design: The study will be performed as a single centre, randomised, placebo controlled trial. 153 patients
scheduled for propofol/alfentanil sedation during colonoscopy will be randomly assigned to receive electroacupuncture
(P6, ST36, LI4), sham acupuncture, or placebo acupuncture. Following endoscopy patients and gastroenterologists have
to fill in questionnaires about their sedation experiences. Additionally, patients have to accomplish the Trieger test before
and after the procedure. Patient monitoring includes time adapted HR, SpO2, ECG, NIBP, exCO2, OAA/S, and the Aldrete
score. The primary outcome parameter is the dosage of propofol necessary for an adequate level of sedation to tolerate
the procedure (OAA/S < 4). Effectiveness of sedation, classified by satisfaction levels measured by questionnaires is the
secondary outcome parameter.
Discussion: Moderate to deep sedation using propofol is increasingly applied during colonoscopies with a high
satisfaction level among patients despite well-known hemodynamic and respiratory side effects of this hypnotic
agent. Acupuncture is known to attenuate gastrointestinal discomfort and pain. We hypothesize that the combination of
conventional sedation techniques with acupuncture may result in equally satisfied patients with a lower risk of respiratory
and hemodynamic events during colonoscopies.
Trial registration: This trial is registered in the Nederland’s Trial Register NTR 4325.
The first patient was randomized on 13 February 2014.
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Background
Colonoscopies are known to be uncomfortable for
patients. Pain and vasovagal reactions often necessitate
administration of sedative or analgesic agents, or even
the combination of both.
Propofol as a sedative agent has a rapid onset and
termination of action, making it the ideal choice for
endoscopic procedures. The most important disadvan-
tage -especially in combination with an opioid- is the
risk of a rapid change from conscious to deep sedation
or even general anaesthesia with consecutive cardiore-
spiratory depression. Therefore, an important clinical
question is, how to reduce the necessary dosage of pro-
pofol and the risks involved while retaining a satisfactory
sedation for patient and endoscopist. Additional acu-
puncture could be an option to solve this problem.
Acupuncture is used worldwide for different indica-
tions, mainly for pain management [1–4]. However,
only few publications exist with respect to the role of
acupuncture for sedation during gastrointestinal pro-
cedures. Fanti et al. could show that the combination
of LI4, S36, SP6 and SP9 can decrease the demand
for sedative drugs [5]. Leung et al. [6] demonstrated
that electro-acupuncture at P6, ST36 and LI4 can re-
duce discomfort and pain during barostat-induced
rectal distension. Ni et al. [7] found a significant re-
duction in stress response and dosage of midazolam
during colonoscopy by acupuncture using ST36,
ST37, SP6, SP9, and LI4.
However, it is not clear whether these effects are a
result of acupuncture or simply a strong placebo ef-
fect [8]. The theoretical basis of acupuncture is still
not known. Two reviews report that there is no evi-
dence for an effect of ‘true’ acupuncture over acu-
puncture at “non points” (sham-acupuncture) [9, 10].
Release of neurotransmitters, parasympathetic disin-
hibition, or even placebo effect could also be explana-
tions for the acupuncture results. Until now no study
demonstrated a link between these effects and specific
acupuncture points.
Methods/design
Aim of the study
We hypothesize that “true” acupuncture causes besides an
analgesic also a sedative effect that will lead to a reduction
of the dosage of propofol needed for satisfactory sedation
during colonoscopies.
Satisfactory sedation is defined as an Observer’s
Assessment of Alertness/Sedation Scale (OAA/S) level
2/3. Target controlled infusion (TCI) of propofol is
adapted to achieve this targeted level of sedation.
To test this hypothesis we will compare three
groups. Group 1 will receive verum-acupuncture at
the traditional acupuncture points P6, ST36, LI4,
group 2 will get sham-acupuncture and group 3 will
be the control group with placebo needles.
All three groups will receive standard sedation with
propofol TCI/alfentanil.
Primary endpoint of the study is the used dosage of
propofol - in combination with a limited dosage of
alfentanil.
Secondary endpoint is patients’ and gastroenterolo-
gists’ satisfaction with the procedure, determined with
validated questionnaires.
Trial design
The study is designed as a single centre, randomised,
placebo controlled trial and reported following the
STRICTA (Standards for Reporting Interventions in
Clinical Trials of Acupuncture) reporting guidelines
[11], and the CONSORT statement [12].
Participants
Number of patients’ needed
Sample size calculation is based on observational propo-
fol data from previous colonoscopies, collected in our
hospital sedation database. Primary end-point is the dif-
ference in the dosage of propofol. The mean dosage of
propofol during colonoscopy is 441 mg, with a standard
deviation of 176 mg [13]. We will need to study 47 sub-
jects in each group, given a power of 0.80 and a type I
error of 0.05 to reduce propofol requirement by about
25 %. Considering a dropout rate of 10 %, the estimated
sample size will be 51 patients per group, thus a total of
153 patients will be randomized.
Eligibility
The study takes place at the Department of Gastroenter-
ology and Hepatology in the Academic Medical Centre
(AMC) of the University of Amsterdam beginning February
2014 to August 2016. Eligible patients for participation in
this clinical trial are those planned to undergo elective diag-
nostic or therapeutic colonoscopy under propofol/alfentanil
sedation, aged above 18 years, and ASA classification I-III,
who give written informed consent.
Exclusion criteria
 Age < 18 years
 ASA classification VI and V
 Allergic reaction to planned medication in the
patients’ medical history
 Nickel allergy
 Pacemaker/Implanted Cardioverter Device
 Psychiatric and neurologic disorders
 Use of anticoagulants
 Refusing sedation
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The number of excluded patients and the reasons for
their exclusion will be reported according to the CON-
SORT statement.
Consent
Patients scheduled for an elective colonoscopy will be
asked – after checking inclusion and exclusion criteria -
by phone to participate. If they are eligible for inclusion
and interested in participating in the study, patient infor-
mation will be sent. Final inclusion occurs after written
informed consent. If they deny taking part they will be
sedated with propofol and alfentanil without any form of
needling. Cardiovascular monitoring using oxygen satur-
ation (SpO2), heart rate (HR), ECG, non-invasive blood
pressure (NIBP) and exhaled CO2 (exCO2) will be per-
formed in all patients at 5-min intervals. The investiga-
tor (physician performing the acupuncture or physician
performing the examination) can decide to withdraw a
subject from the study for urgent medical reasons (aller-
gic reactions, extreme pain on acupuncture points, acute
health problems).
Randomization
After the patient has signed the informed consent form,
randomization will be performed as a permuted block
randomization (RITA version 1.31). Allocation to treat-
ment group will be performed by sealed consecutively
numbered envelopes.
One experienced and qualified staff acupuncturist
(4 years in practice) will perform the intervention, but is
not further involved in the study. After the patient is se-
dated and before colonoscopy starts the acupuncturist
will open the allocation envelope.
Intervention
After randomization patients are prepared for endos-
copy. Glycopyrrolate 0.2 mg and lidocaine 50 mg are
administered intravenously, and patients are positioned
in right lateral position. Via a nasal cannula 2 L/min of
oxygen will be given from start of sedation till the end of
the endoscopic procedure.
Each group will receive sedation - supplied by a
specialized anaesthesia nurse (sedation specialist) -
using a propofol TCI system that is weight and age
adapted. The Marsh pharmacokinetic model is
employed to attain a pre-set propofol plasma target
level.
The targeted sedation score – measured by Observer’s
Assessment of Alertness/Sedation OAAS Scale - should
be 2 or 3, which means patients response maximal leth-
argic if their name is called loudly and/or repeatedly or
after mild prodding or shaking.
If OAA/S ≥ 4, which means that the patient is too alert
or agitated to tolerate the procedure, additional sedation
will be provided with step up of the TCI.
Additionally, when starting propofol TCI, patients will
be given 1.5 μg/kg alfentanil.
We use the Behavioural Pain Scale for not-intubated
patients (BPS-NI) [14]. The BPS–NI evaluates three be-
havioural domains (i.e., facial expression, movements of
upper limbs and vocalization). Each domain contains
four descriptors that are rated on a 1–4 scale, with a
value ranges from 3 (no pain) to 12 (most pain). Patients
with BPS-NI ≥ 7 were given an additional dose of 1,5 μg/kg
alfentanil.
After starting propofol sedation and reaching the
targeted sedation score (OAAS 2/3), the needles are
placed by the acupuncturist according to allocation
(Fig. 1) and connected to a six-channel programmable
electrical stimulator (SVESA 1031, Germany, Munich).
Stimulation frequency (1–10 Hz) should be high
enough to provoke muscle contraction. In the control
group, the stimulator will likewise be connected but
without electrical stimulation. The intervention with
electroacupuncture will be stopped as soon as the
colonoscopy is finished.
After endoscopic examination the position of the nee-
dles will be checked. If some of the needles are not in
place any more after colonoscopy, it will be documented
in the CRF.
Group 1 will have verum acupuncture unilateral on
three points according the theory of Traditional Chinese
medicine. Nickel needles (Asia-med, Germany, Special
No. 16 (0.30x30 mm / (Gauge 8x1.2") will be placed and
left in their position for five minutes prior and throughout
the endoscopic procedure. We choose the following
points, which are considered relevant both - for sedation
and for abdominal distension: Pericardium 6 (P6),
Stomach 36 (ST36), and Large intestine 4 (LI4). The
localization of these points is described in units of cun.
Cun is a traditional Chinese unit of length. One cun is de-
fined as the width of a persons thumb, whereas four fin-
gers are defined as 3 cun. This corresponds to about 3 cm
of length.
There are no specific acupuncture points known for
their sedative effect. Large intestine 4 (LI4), Pericardium 6
(P6) and Stomach 36 (ST36) is the most used combination
to reduce gastrointestinal discomfort and pain [5, 7] with
a consecutive sedation side effect [15].
Pericard 6 (P6) is stimulated with various acupuncture
techniques, especially used for preventing and
treatment of nausea and vomiting. It is located on the
skin of the anterior forearm, two cun above to the wrist
crease, between the tendons of m. palmaris longus and
m. flexor carpi radialis.
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The second point is Stomach 36 (ST36). It is located
below the knee, one-finger breadth lateral to the anterior
crest of the tibia and 3 cun inferior to the hollow that is
formed below the patella, and lateral to the patellar liga-
ment when the knee is flexed. It is supposed to be the
acupoint with the most influence on the gastro-intestinal
tract.
These two acupoints are combined with Large
intestine 4 (LI4) located on the dorsum of the hand
between the first and second metacarpal bones at
the midpoint of the second metacarpal bone, and
close to its radial border. LI4 is one of the most
used acupoints, frequently in combination with other
acupoints for the treatment of pain and intestinal
diseases [16].
Group 2 will receive Sham-acupuncture with the same
sort of needles. The needles will be placed 1 cm distal
and lateral the used acupoints (P6, ST36, LI4) on non-
points - locations that are not known as acupuncture
points.
Group 3 will have sham acupuncture with placebo
needles (Streitberger needles, Asia-med, Germany,
0.30x30 mm / (Gauge 8x1.2") on the same points used
for sham- acupuncture to exclude a significant effect of
acupressure on the regular acupuncture points.
The Streitberger needle looks like a real needle but
has a blunt tip whose shaft telescopes into the handle
during application without penetrating the skin [17].
Resident and senior endoscopists – reflecting the
spectrum of a teaching hospital-will perform colonoscopy.
A not blinded medical student will document and
monitor the procedure in the endoscopy and recovery
room.
The other attending parties (patient, sedation anaes-
thesia nurse, endoscopist, endoscopic nurse) are blinded
and not informed about the allocation.
At arrival in the recovery room patients will be moni-
tored by SpO2, ECG and NIBP only.
The level of recovery from sedation and the return of
psychomotor fitness will be assessed using the modified
Aldrete Score directly at the end of the procedure, at ar-
rival in the recovery room, 30 and 60 min thereafter. All
patients will stay in the recovery room for at least
60 min. Ready for discharge (virtual discharge) will be
declared when an Aldrete Score ≥9 or pre-procedure
score is met.
“Discharge criteria” require further that the patient is
awake and alert with stable vital signs, is able to ambu-
late without assistance, and is free of side effects of the
drugs employed during the procedure.
Primary objective
Definition of primary endpoint
The primary aim of this randomised controlled study is
to determine whether application of acupuncture de-
creases the total dosage of propofol needed to reach a
sedation level of OAAS 2/3 during colonoscopies.
We also want to clarify, whether a reduction in the
dosage of sedatives will result in a reduction of side ef-
fects of sedation, especially respiratory and circulatory
depression, nausea and vomiting, and may lead to a fas-
ter recovery.
Assessment of primary endpoint
We will record total amount of propofol and alfentanil,
and all other drugs administered, psychomotoric recov-
ery, hemodynamic and respiratory parameters and
events, and all actions visibly taken to prevent or treat
these problems, such as chin lift/jaw thrust, stimulating
the patient, temporary mask ventilation, use of ephe-
drine or phenylephrine, etc.
Psychomotoric recovery is assessed by the Trieger test
[18]. For this test patients have to connect points
Fig. 1 Acu-points (white) vs. sham-acupoints (red)
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forming a figure with a line using a pen, before and
30 min after the procedure. Missing points as well as the
distances of the line from the true points are noted and
rated as score post/preprocedural.
HR, NIBD and SpO2 are reported as area under the
curve (AUC). Surrogate parameters of pulmonary and
cardiovascular events are a decline in SpO2 to less than
90 %, or breathing frequency less than 6 breath/min; a
change in HR to less or more than 20 % of baseline or
occurrence of any arrhythmia’s; NIBP less or more than
20 % of the first value determined. The events will be re-
corded, if they are longer lasting than 5 min of request
intervention.
Secondary objective
Definition of secondary endpoint
Patients’ and endoscopists’ satisfaction with the entire
procedure is defined as secondary endpoint.
Assessment of secondary endpoint
Satisfaction will be evaluated by means of validated
questionnaires [19].
Before the procedure, patients and endoscopists will
fill in a questionnaire concerning basic information and
specific expectations of the procedure. Following the
procedure and before discharge, patients and gastroen-
terologists are urged to fill in questionnaires modified
from the Patient Satisfaction with Sedation Instrument
(PSSI), respectively Clinical Satisfaction with Sedation
Instrument (CSSI). A follow-up telephone call will be
made 24 h later asking questions from part two of the
PSSI questionnaire concerning global satisfaction.
Vargo et al. [19] developed these questionnaires with
finally 4 subscores to describe patients and 3 subscores
to describe endoscopists’ satisfaction. Subscores for the
PSSI contain questions about sedation delivery, proced-
ural recall, sedation side effects, and global satisfaction.
Subscores for the CSSI refer to corresponding issues
among gastroenterologists: Sedation administration, re-
covery/ post-op and global satisfaction. Patients and
endoscopists could classify their satisfaction or dissatis-
faction during the procedure ranging from 7 = very satis-
fied to 1 = very dissatisfied.
The dosage of alfentanil as objective parameter of suf-
fered pain during procedure will also be measured.
Statistical analysis
Statistical analyses will be performed using SPSS
statistics.
All data will be checked for normal distribution using
the Kolmogorov test. For normal distributed, continuous
variables an independent Student’s t - test will be used
and the variables will be presented as mean ± SD. For
normal distributed categorical variables Pearson chi
square test will be applied and variables will be allego-
rized as number and/or percentage of total. Not
normally distributed data will be compared using multi-
factorial ANOVA (Kruska Wallis) or the Whitney U-test
where appropriate. These variables will be presented as
median/25/75 percentile. A p -value < 0.05 will be con-
sidered statistically significant. Confidence intervals are
mentioned where appropriate.
Ethical approval
This trial will be conducted in accordance with the
protocol and in compliance with the moral, ethical, and
scientific principles governing clinical research as set out
in the Declaration of Helsinki (1989) and Good Clinical
Practice (GCP). The Departments of Anesthesiology and
Gastroenterology & Hepatology of the Academic Med-
ical Centre of Amsterdam are responsible for the design
and conduct of the trial. The protocol was designed ac-
cording to the Standards for reporting Interventions in
Clinical Trials Acupuncture (STRICTA) [11]. It is
registered in the Nederland’s Trial Register (NTR
NTR4325). Ethical approval was obtained from the Med-
ical Ethics Committee of the Academic Medical Centre,
Amsterdam, the Netherland (NL). The National Author-
ity, the Central Committee on Research Involving
Human Subjects (CCMO), performed a marginal review
and there were no objections to perform this study
(NL36861.018.11).
Discussion
One might discuss to analyse the data using a non-
inferiority approach because sedation quality after appli-
cation of acupuncture should be at least as good as using
medication only.
However, our motivation in the end to choose for the
superiority approach was: During this trial acupuncture
is performed by only one experienced acupuncturist.
Implementing acupuncture in our daily anaesthesia
sedation praxis would mean additional engagement of
anaesthesia personal to learn and perform acupuncture.
This investment will only be cost-effective if the dosage
of propofol is reduced or - in case of the dosage of pro-
pofol is not influenced, there is an improvement of satis-
faction among patients and endoscopist.
Alongside, safety concerns of deep sedation per-
formed with propofol still remain. Cote et al. showed
that hypoxemia occurred in 12.8 % of 799 patients
sedated for endoscopic procedures with propofol ap-
plied by trained anaesthesia nurses [20]. In 14.4 % of
the patients airway manoeuvres were necessary to
prevent hypoxemia. In our own previous study look-
ing at 180 patients undergoing colonoscopy, 47 % of
all patients with propofol sedation experienced at
least one respiratory incident and 87 % had at least
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one hypotensive event [13]. Minimizing those propo-
fol related risks by means of a superior sedation form
is therefore an important goal to make sedation pro-
cedures safer.
Aside these considerations all groups receive propofol
sedation and therefore using placebo needles is not an
unethical treatment.
Another point of discussion comes up with the ques-
tion: Does acupuncture really have a sedative effect or is
this effect the consequence of its analgesic properties.
Fanti et al. studied three groups of patients scheduled
for colonoscopy [5]. Group 1 got acupuncture, group 2
sham-acupuncture and group 3 placebo. All groups were
premedicated with 0.02-mg/kg midazolam before, and
no analgesic agent was used. If patients complained
about pain during procedure they received additional
boluses of midazolam. To medicate a patient moaning
about pain with a sedative and to conclude that acu-
puncture can decrease the demand for sedatives during
colonoscopy is not the correct conclusion.
So the question whether acupuncture can reduce the
dosage of sedative, and be implemented into the clinical
routine as a complementary sedative method has still to
be answered [21].
Trial status
The first patient was included at 13 February 2014. We
consider including 3 patients per week.
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